RCUS — ARCUS BIOSCIENCES INC

Ownership history in GILEAD SCIENCES, INC.  ·  5 quarters on record

This page tracks every 13F SEC filing in which GILEAD SCIENCES, INC. reported a position in ARCUS BIOSCIENCES INC (RCUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
38.69% (2025 Q4)
Avg. % of fund
26.45%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 31,424,760 — 0% 38.69% $748.9M $23.83
2025 Q3 UNCHANGED 31,424,760 — 0% 23.86% $427.4M $13.60
2025 Q2 UNCHANGED 31,424,760 — 0% 19.98% $255.80B $8.14
2025 Q1 ADDED 31,424,760 +1,363,636 +4.5% 20.88% $246.68B $7.85
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCUS price (monthly, adj. close)

Other funds also holding RCUS

As of 2025 Q4 — sorted by position size

SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.53% DAFNA Capital Management LLC 3Y 7Y 2.39% Parkman Healthcare Partners LLC 3Y 2.2% Siren, L.L.C. 2.14% Decheng Capital LLC 1.74% First Turn Management, LLC 1.54% Logos Global Management LP 3Y 1.51% Knott David M Jr 3Y 1.34% Sofinnova Investments, Inc. 3Y 7Y 1.13% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 1.09%
← Back to GILEAD SCIENCES, INC. Holdings